Evaluation of long-acting somatostatin analog injection devices by nurses: a quantitative study

The somatostatin analogs (SSAs) lanreotide Autogel/Depot and octreotide long-acting release are used to treat acromegaly and neuroendocrine tumors. The present study evaluated opinions on SSA injection devices, including a recently approved lanreotide new device (lanreotide-ND), among nurses in Euro...

Descripción completa

Detalles Bibliográficos
Autores principales: Adelman, Daphne T, Burgess, Andrea, Davies, Philippa R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534535/
https://www.ncbi.nlm.nih.gov/pubmed/23293542
http://dx.doi.org/10.2147/MDER.S37831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534535/
https://www.ncbi.nlm.nih.gov/pubmed/23293542
http://dx.doi.org/10.2147/MDER.S37831

Ejemplares similares